Gary Dannatt

Gary Dannatt serves as Chief Operating Officer at Pharmacy2U Ltd. Pharmacy2U Ltd operates in the pharmaceuticals sector with approximately 440.0 employees. The company is headquartered in London, England. Pharmacy2U Ltd generates annual revenue of 220796000.0. To date, Pharmacy2U Ltd has raised 78959682.0 in total funding, with the most recent round being Venture (Round not Specified).

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,468 c suite-level executives.

Cloudflare DNS Amazon SES Outlook Sailthru CloudFlare Hosting Taboola Newsroom TubeMogul Atlassian Cloud AI

nhs repeat prescriptions private prescriptions online doctor service pharmaceutical manufacturing online pharmacy prescription delivery digital healthcare health & beauty products pet health products convenience patient-centric healthcare accessibility e-commerce chronic condition management technology-driven service customer satisfaction trustpilot rating health tools blood pressure check carer accounts competitive pricing innovative technology healthcare partnerships digital-first model patient safety clinical excellence health & wellness prescription management customer loyalty uk healthcare market pharmacy services distance dispensing healthcare solutions patient experience brand awareness convenience-driven healthcare pharmaceuticals medical consumer internet consumers internet information technology & services health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Gary Dannatt in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Pharmacy2U Ltd.

Gary Dannatt's Position in the MessageCEO Database

• •Gary Dannatt is 1 of 1 verified executive contact we track at Pharmacy2U Ltd.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •10,040 verified executive contacts in England are in the database.
• •4 verified contacts work at pharmaceuticals companies in the 440.0 employee range (same size as Pharmacy2U Ltd).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Gary Dannatt directly?

Gary Dannatt's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Operating Officer at Pharmacy2U Ltd. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Gary Dannatt work for?

Gary Dannatt is Chief Operating Officer at Pharmacy2U Ltd, a company in the pharmaceuticals sector with 440.0 employees. The company is based in London, England.

Can I pitch or sell to Gary Dannatt?

As Chief Operating Officer at Pharmacy2U Ltd, Gary Dannatt is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Gary Dannatt directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Gary Dannatt in?

Gary Dannatt works in the pharmaceuticals industry as Chief Operating Officer at Pharmacy2U Ltd. MessageCEO provides verified contact information for executives across all major industries.

Is Gary Dannatt's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Gary Dannatt's profile is kept up-to-date with the latest available information.

Last updated: July 25, 2026